Marie‐Laure Risse

3.5k citations
37 papers · 2.7k · 2 hit papers · h-index 16

Impact in

Papers in

    • Multiple Myeloma Research and Treatments 31
    • Pharmacogenetics and Drug Metabolism 1

Marie‐Laure Risse

36 papers receiving 2.6k citations

Marie‐Laure Risse's Hit Papers

Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial 2021 · 290 citations
2900+6+13Years since publication50010001.5k

Peers

Marie‐Laure Risse
Comparison fields: 5 of 51
  • Hematology 672
  • Pulmonary and Respiratory Medicine 1.0k
  • Pharmacology 85
  • Oncology 149
  • Surgery 234
Replace Aaron Weitzman with:
Aaron Weitzman United States
Kurt W. Brunner Switzerland
Naseem J. Zojwalla United States
Edouard Voznyi Russia
Paola Aimone Switzerland
Kelly B. Pendergrass United States
Heidi H. Gillenwater United States
Giovanni Lo Re Italy
Michael Paul Fanucchi United States
Norbert Schleucher Germany
Marie‐Laure Risse relative to Aaron Weitzman United States Aaron Weitzman's profile →
Citations per field
00.5×5×10×14.6×
Aaron Weitzman · 1×
Citations per year

Countries citing papers authored by Marie‐Laure Risse

Since Specialization
Citations

This map shows the geographic impact of Marie‐Laure Risse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie‐Laure Risse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie‐Laure Risse more than expected).

Fields of papers citing papers by Marie‐Laure Risse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie‐Laure Risse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie‐Laure Risse. The network helps show where Marie‐Laure Risse may publish in the future.

Co-authors

The 25 scholars most cited alongside Marie‐Laure Risse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marie‐Laure Risse Line = papers co-authored together Marie‐Laure Risse links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group
Hit paper breakdown →
20061619
2
Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial
Hit paper breakdown →
2021290
3
Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans.
2000190
4 200391
5 202373
6 201760
7 201957
8 202141
9 200036
10 201334
11 202028
12 202123
13 202219
14 202417
15 202116
16 202216
17 202216
18 202014
19 202313
20 202212

About Marie‐Laure Risse

Marie‐Laure Risse is a scholar working on Hematology, Pharmacology, Oncology, Pulmonary and Respiratory Medicine and Surgery, having authored 37 papers that have together received 2.7k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (31 papers), Bladder and Urothelial Cancer Treatments (1 paper), Pharmacogenetics and Drug Metabolism (1 paper), Cancer therapeutics and mechanisms (1 paper), Colorectal Cancer Treatments and Studies (1 paper) and Gastric Cancer Management and Outcomes (1 paper). The work is most often cited by research in Hematology (672 citations), Pulmonary and Respiratory Medicine (1.0k citations), Pharmacology (85 citations), Oncology (149 citations) and Surgery (234 citations). Marie‐Laure Risse has collaborated with scholars based in France, United States and Czechia. Frequent co-authors include Sergei Tjulandin, Edouard Voznyi, Alejandro Majlis, Vladimir Mikhailovich Moiseyenko, Adriano Rodrigues, Manuel Constenla, Corrado Boni, Jaffer A. Ajani, M Fodor and Yee Chao. Their work appears in journals such as Blood, Journal of Clinical Oncology, Hematological Oncology, HemaSphere and Transplantation and Cellular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact